| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Revenue | $389.1M | +25.3% |
| Cost of Revenue | $153.2M | +16.0% |
| Gross Profit | $235.9M | +32.1% |
| R&D Expense | $226.4M | +12.4% |
| SG&A Expense | $94.2M | +15.8% |
| Operating Income | -$324.4M | -1.9% |
| Pre-tax Income | -$287.7M | -3.2% |
| Income Tax | $976K | +23.2% |
| Net Income | -$288.7M |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $164.4M | -1.7% |
| Short-term Investments | $578.3M | -0.8% |
| Accounts Receivable | $137.2M | +5.5% |
| Current Assets | $904.3M | -0.0% |
| Total Assets | $1.03B | -1.2% |
| Current Liabilities | $131.9M | +28.9% |
| Total Liabilities | $187.6M | +13.8% |
| Line Item | 2025-04-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$41.4M | +33.6% |
| Capital Expenditures | $3.0M | -88.0% |
| Investing Cash Flow | $16.4M | +124.6% |
| Financing Cash Flow | $22.2M | +96.8% |
| Free Cash Flow | -$44.4M | +49.3% |
| -3.2% |
| EPS (Basic) | -$2.24 | +4.3% |
| EPS (Diluted) | -$2.24 | +4.3% |
| Stockholders' Equity |
| $838.3M |
| -4.0% |